Reports - Liquid Biopsy Market
Biotechnology and Life SciencesLiquid Biopsy Market
Liquid Biopsy Market Size Analysis Report 2025-2035 by Product & Services (Assay Kits, Instruments, Services) by Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Extracellular Vesicles (EVS), Other Circulating Biomarkers) by Clinical Applications (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring) by Technology (Multi-Gene Parallel Analysis using NGS, Single-Gene Analysis using PCR Microarrays) by Application (Cancer Applications, Non-Cancer Applications) by Sample Type (Blood, Other Sample Types) by End User (Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Liquid Biopsy Market - Segment Analysis
1. Overview
2. Global Liquid Biopsy Market, 2021 - 2035 (USD Million)
3. Global Liquid Biopsy Market - by Product & Services
3.1. By Assay Kits
3.2. By Instruments
3.3. By Services
4. Global Liquid Biopsy Market - by Circulating Biomarkers
4.1. By Circulating Tumor Cells
4.2. By Circulating Tumor DNA (ctDNA)
4.3. By Circulating Tumor DNA (ctDNA)
4.4. By Cell-free DNA (cfDNA)
4.5. By Extracellular Vesicles (EVS)
4.6. By Other Circulating Biomarkers
5. Global Liquid Biopsy Market - by Clinical Applications
5.1. By Early Cancer Screening
5.2. By Therapy Selection
5.3. By Treatment Monitoring
5.4. By Recurrence Monitoring
6. Global Liquid Biopsy Market - by Technology
6.1. By Multi-Gene Parallel Analysis using NGS
6.2. By Single-Gene Analysis using PCR Microarrays
7. Global Liquid Biopsy Market - by Application
7.1. By Cancer Applications
7.2. By Non-Cancer Applications
8. Global Liquid Biopsy Market - by Sample Type
8.1. By Blood
8.2. By Other Sample Types
9. Global Liquid Biopsy Market - by End User
9.1. By Reference Laboratories
9.2. By Hospitals & Physician Laboratories
9.3. By Academic & Research Centers
9.4. By Other End Users
10. Global Liquid Biopsy Market - by region
10.1. North America
10.2. Europe
10.3. Asia Pacific
10.4. Latin America
10.5. Middle East & Africa
11. Market comparative analysis
Chapter 4 North America Liquid Biopsy Market - Segment Analysis
1. Overview
2. North America Liquid Biopsy Market, 2021 - 2035 (USD Million)
3. North America Liquid Biopsy Market - by Product & Services
3.1. By Assay Kits
3.2. By Instruments
3.3. By Services
4. North America Liquid Biopsy Market - by Circulating Biomarkers
4.1. By Circulating Tumor Cells
4.2. By Circulating Tumor DNA (ctDNA)
4.3. By Circulating Tumor DNA (ctDNA)
4.4. By Cell-free DNA (cfDNA)
4.5. By Extracellular Vesicles (EVS)
4.6. By Other Circulating Biomarkers
5. North America Liquid Biopsy Market - by Clinical Applications
5.1. By Early Cancer Screening
5.2. By Therapy Selection
5.3. By Treatment Monitoring
5.4. By Recurrence Monitoring
6. North America Liquid Biopsy Market - by Technology
6.1. By Multi-Gene Parallel Analysis using NGS
6.2. By Single-Gene Analysis using PCR Microarrays
7. North America Liquid Biopsy Market - by Application
7.1. By Cancer Applications
7.2. By Non-Cancer Applications
8. North America Liquid Biopsy Market - by Sample Type
8.1. By Blood
8.2. By Other Sample Types
9. North America Liquid Biopsy Market - by End User
9.1. By Reference Laboratories
9.2. By Hospitals & Physician Laboratories
9.3. By Academic & Research Centers
9.4. By Other End Users
Chapter 5 Europe Liquid Biopsy Market - Segment Analysis
1. Overview
2. Europe Liquid Biopsy Market, 2021 - 2035 (USD Million)
3. Europe Liquid Biopsy Market - by Product & Services
3.1. By Assay Kits
3.2. By Instruments
3.3. By Services
4. Europe Liquid Biopsy Market - by Circulating Biomarkers
4.1. By Circulating Tumor Cells
4.2. By Circulating Tumor DNA (ctDNA)
4.3. By Circulating Tumor DNA (ctDNA)
4.4. By Cell-free DNA (cfDNA)
4.5. By Extracellular Vesicles (EVS)
4.6. By Other Circulating Biomarkers
5. Europe Liquid Biopsy Market - by Clinical Applications
5.1. By Early Cancer Screening
5.2. By Therapy Selection
5.3. By Treatment Monitoring
5.4. By Recurrence Monitoring
6. Europe Liquid Biopsy Market - by Technology
6.1. By Multi-Gene Parallel Analysis using NGS
6.2. By Single-Gene Analysis using PCR Microarrays
7. Europe Liquid Biopsy Market - by Application
7.1. By Cancer Applications
7.2. By Non-Cancer Applications
8. Europe Liquid Biopsy Market - by Sample Type
8.1. By Blood
8.2. By Other Sample Types
9. Europe Liquid Biopsy Market - by End User
9.1. By Reference Laboratories
9.2. By Hospitals & Physician Laboratories
9.3. By Academic & Research Centers
9.4. By Other End Users
Chapter 6 Asia Pacific Liquid Biopsy Market - Segment Analysis
1. Overview
2. Asia Pacific Liquid Biopsy Market, 2021 - 2035 (USD Million)
3. Asia Pacific Liquid Biopsy Market - by Product & Services
3.1. By Assay Kits
3.2. By Instruments
3.3. By Services
4. Asia Pacific Liquid Biopsy Market - by Circulating Biomarkers
4.1. By Circulating Tumor Cells
4.2. By Circulating Tumor DNA (ctDNA)
4.3. By Circulating Tumor DNA (ctDNA)
4.4. By Cell-free DNA (cfDNA)
4.5. By Extracellular Vesicles (EVS)
4.6. By Other Circulating Biomarkers
5. Asia Pacific Liquid Biopsy Market - by Clinical Applications
5.1. By Early Cancer Screening
5.2. By Therapy Selection
5.3. By Treatment Monitoring
5.4. By Recurrence Monitoring
6. Asia Pacific Liquid Biopsy Market - by Technology
6.1. By Multi-Gene Parallel Analysis using NGS
6.2. By Single-Gene Analysis using PCR Microarrays
7. Asia Pacific Liquid Biopsy Market - by Application
7.1. By Cancer Applications
7.2. By Non-Cancer Applications
8. Asia Pacific Liquid Biopsy Market - by Sample Type
8.1. By Blood
8.2. By Other Sample Types
9. Asia Pacific Liquid Biopsy Market - by End User
9.1. By Reference Laboratories
9.2. By Hospitals & Physician Laboratories
9.3. By Academic & Research Centers
9.4. By Other End Users
Chapter 7 Latin America Liquid Biopsy Market - Segment Analysis
1. Overview
2. Latin America Liquid Biopsy Market, 2021 - 2035 (USD Million)
3. Latin America Liquid Biopsy Market - by Product & Services
3.1. By Assay Kits
3.2. By Instruments
3.3. By Services
4. Latin America Liquid Biopsy Market - by Circulating Biomarkers
4.1. By Circulating Tumor Cells
4.2. By Circulating Tumor DNA (ctDNA)
4.3. By Circulating Tumor DNA (ctDNA)
4.4. By Cell-free DNA (cfDNA)
4.5. By Extracellular Vesicles (EVS)
4.6. By Other Circulating Biomarkers
5. Latin America Liquid Biopsy Market - by Clinical Applications
5.1. By Early Cancer Screening
5.2. By Therapy Selection
5.3. By Treatment Monitoring
5.4. By Recurrence Monitoring
6. Latin America Liquid Biopsy Market - by Technology
6.1. By Multi-Gene Parallel Analysis using NGS
6.2. By Single-Gene Analysis using PCR Microarrays
7. Latin America Liquid Biopsy Market - by Application
7.1. By Cancer Applications
7.2. By Non-Cancer Applications
8. Latin America Liquid Biopsy Market - by Sample Type
8.1. By Blood
8.2. By Other Sample Types
9. Latin America Liquid Biopsy Market - by End User
9.1. By Reference Laboratories
9.2. By Hospitals & Physician Laboratories
9.3. By Academic & Research Centers
9.4. By Other End Users
Chapter 8 Middle East & Africa Liquid Biopsy Market - Segment Analysis
1. Overview
2. Middle East & Africa Liquid Biopsy Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Liquid Biopsy Market - by Product & Services
3.1. By Assay Kits
3.2. By Instruments
3.3. By Services
4. Middle East & Africa Liquid Biopsy Market - by Circulating Biomarkers
4.1. By Circulating Tumor Cells
4.2. By Circulating Tumor DNA (ctDNA)
4.3. By Circulating Tumor DNA (ctDNA)
4.4. By Cell-free DNA (cfDNA)
4.5. By Extracellular Vesicles (EVS)
4.6. By Other Circulating Biomarkers
5. Middle East & Africa Liquid Biopsy Market - by Clinical Applications
5.1. By Early Cancer Screening
5.2. By Therapy Selection
5.3. By Treatment Monitoring
5.4. By Recurrence Monitoring
6. Middle East & Africa Liquid Biopsy Market - by Technology
6.1. By Multi-Gene Parallel Analysis using NGS
6.2. By Single-Gene Analysis using PCR Microarrays
7. Middle East & Africa Liquid Biopsy Market - by Application
7.1. By Cancer Applications
7.2. By Non-Cancer Applications
8. Middle East & Africa Liquid Biopsy Market - by Sample Type
8.1. By Blood
8.2. By Other Sample Types
9. Middle East & Africa Liquid Biopsy Market - by End User
9.1. By Reference Laboratories
9.2. By Hospitals & Physician Laboratories
9.3. By Academic & Research Centers
9.4. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Bio-Rad Laboratories
2. Biocept Inc.
3. Guardant Health
4. Illumina Inc.
5. F. Hoffmann-La Roche Ltd.
6. Johnson & Johnson
7. Laboratory Corporation of America Holdings
8. MDxHealth SA
9. QIAGEN N.V.
10. Thermo Fisher Scientific Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By